Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día

  1. Adolfo Piñón 1
  2. Mayte Lage 2
  3. Indalecio Carrer 2
  4. Marta Vázquez 2
  5. Xaqueline Cerqueiro 2
  6. Victoria Bobadilla 2
  7. Carlos Spuch 2
  8. Francisco Otero 1
  1. 1 Unidad Asistencial de Drogodependencias (CEDRO), Vigo, España
  2. 2 Unidad Asistencial de Drogodependencias de la Asociación Ciudadana de Lucha contra la Droga (ACLAD), Coruña, España
Journal:
Health and addictions: salud y drogas

ISSN: 1578-5319

Year of publication: 2019

Volume: 19

Issue: 1

Pages: 70-79

Type: Article

DOI: 10.21134/HAAJ.V19I1.412 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Health and addictions: salud y drogas

Sustainable development goals

Abstract

The consumption of psychoactive substances has been consistently associated with the presence of alterations in different neuropsychological processes: speed of processing, memory, attention or executive functions, which have been related to deterioration in daily functioning and less effectiveness of conventional treatments, and justify the need for integrate the neuropsychological approach in the treatment of addictions. The objective of this work is to study the neuropsychological and symptomatological alterations in patients with substance-related disorders. A neuropsychological evaluation was applied to a sample of people with disorders related to a treatment in a day unit. The results reflect a neuropsychological performance indicative of moderate cognitive impairment, reduced speed of psychomotor, reading and visuospatial processing, deficits in the subprocesses of sustained attention, selective and alternating, and difficulties in the executive components of inhibition and cognitive flexibility. At the level of psychopathological symptoms, clinical manifestations of obsession-compulsion, depression, anxiety and psychoticism have been found. The determination of the neuropsychological and symptomatological profile in these patients contributes to improve diagnosis, work awareness of the deficit and optimize the individualization of treatment programs.

Bibliographic References

  • Aguilar, F., Verdejo, A., López, A., Montañez, M., Gómez, E., Arráez, F. & Pérez, M. (2008). Respuesta emocional ante estímulos afectivos en sujetos adictos a opiáceos bajo consumo controlado en el P.E.P.S.A. Adicciones, 20, 27-35. http://dx.doi.org/10.20882/adicciones.286.
  • Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and alcohol dependence, 81(3), 313-322.
  • American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders; DSM-III. Washington DC.
  • American Psychatric Association. (2014). Manual Diagnóstico y Estadístico de los Trastornos Mentales DSM-5.
  • Barry, D. & Petry, N.M. (2008). Predictors of decision-making on the Iowa Gambling Task: independent effects of lifetime history of substance use disorders and performance on the Trail Making Test. Brain & Cognition, 66, 243–252.
  • http://dx.doi.org/10.1016/j.bandc.2007.09.001
  • Bechara, A., Damasio, A.R., Damasio, H. & Anderson, S.W. (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition, 50, 7-15.
  • Benton, A. L., & Hamsher, K. D. S. (1976). Multilingual aphasia examination Iowa City.
  • Bolla, K. I., Eldreth, D. A., London, E. D., Kiehl, K. A., Mouratidis, M., Contoreggi, C. E. E. A., ... & Funderburk, F. R. (2003). Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage, 19(3), 1085-1094.
  • Bonet Álvarez, J., Salvador Castellano, A., Torres Rivas, C., Aluco Sánchez, E., Cano, M., & Palma Sevillano, C. (2015). Consumo de cocaína y estado de las funciones ejecutivas.
  • Busch, R. M., McBride, A., Curtiss, G., & Vanderploeg, R. D. (2005). The components of executive functioning in traumatic brain injury. Journal of clinical and experimental neuropsychology, 27(8), 1022-1032.
  • Campbell, B. K., & Stark, M. J. (1990). Psychopathology and personality characteristics in different forms of substance abuse. International journal of the addictions, 25(12), 1467-1474.
  • Casals-Coll, M., Sánchez-Benavides, G., Quintana, M., Manero, R. M., Rognoni, T., Calvo, L., ... & Pena-Casanova, J. (2013). Spanish normative studies in young adults (NEURONORMA young adults project): norms for verbal fluency tests. Neurología (English Edition), 28(1), 33-40.
  • Coullaut-Valera, R., Arbaiza-Diaz del Rio, I., Arrúe-Ruilo, R., Coullaut-Valera, J. y Bajo Breton, R. (2011). Deterioro cognitivo asociado al consumo de diferentes sustancias psicoactivas. Actas Españolas de Psiquiatría, 39,168-73.
  • Damasio, A.R. (1994). Descartes’ error: emotion, reason, and the human brain. New York: Grosset/Putnam.
  • De España, J. C. I. R. (1999). Ley Orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal. Bol Del Estado, 298(2), 43088-43099.
  • Derogatis, L. R. (1977). Administration, scoring, and procedures manual for the SCL-90-R. Baltimore, MD: Clinical Psychometrics Research.
  • Durán, A. L., & Iglesias, E. B. (2006). Consumo de cocaína y psicopatología asociada: una revisión. Adicciones, 18(2), 161-196.
  • Fernández-Montalvo, J., Lorea, I., López-Goñi, J. J., & Landa González, N. (2008). Comorbilidad psicopatológica en la adicción a la cocaína: Resultados con el SCL-90-R. Behavioral Psychology/Psicología Conductual, 16 (2), 275-288.
  • Fernández-Serrano, M.J., Pérez-García, M., Schmidt Río-Valle, J. & Verdejo-García, A. (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of psychopharmacology, 24 (9), 1317–1332. http://dx.doi.org/10.1177/0269881109349841
  • Fernández-Serrano, M. J., Pérez-García, M. & Verdejo-García, A. (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35, 377-406.
  • Flores, E., Aragón Cancela, C., Chicharro Romero, J., Ezpeleta, D., Fernández Espejo, E., García Fernández, G., ... & Llanero Luque, M. (2009). Documento de consenso para el abordaje de las adicciones desde las neurociencias. Trastornos adictivos, 11(4), 243-246.
  • García Fernández, G., García Rodríguez, O. & Secades Villa, R. (2011). Neuropsicología y adicción a drogas. Papeles del Psicólogo.
  • García, A. V. (2006). Funciones ejecutivas y toma de decisiones en drogodependientes: rendimiento neuropsicológico y funcionamiento cerebral (Doctoral dissertation, Universidad de Granada).
  • Garavan, H. & Stout, J. C. (2005). Neurocognitive insights into substance abuse. Trends in Cognitive Sciences, 9, 195-201.
  • Golden, C. J. (1999). Stroop: Test de colores y palabras. Tea.
  • Goldstein, R. Z., Leskovjan, A. C., Hoff, A. L., Hitzemann, R., Bashan, F., Khalsa, S. S., ... & Volkow, N. D. (2004). Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia, 42(11), 1447-1458.
  • Kalivas, P.W. & Volkow, N.D. (2005). The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry, 162, 1403-1413.
  • López-Goñi, J. J., Fernández-Montalvo, J., Cacho, R., & Arteaga, A. (2014). Profile of addicted patients who reenter treatment programs. Substance abuse, 35(2), 176-183.
  • López-Goñi, J. J., Fernández-Montalvo, J., & Arteaga, A. (2015). Differences between alcoholics and cocaine addicts seeking treatment. The Spanish journal of psychology, 18.
  • Maremmani, A. G., Gazzarrini, D., Fiorin, A., Cingano, V., Bellio, G., Perugi, G., & Maremmani, I. (2018). Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?. Annals of general psychiatry, 17(1), 3.
  • Martínez, J.M. & Verdejo, A. (2011). Creencias básicas adictivas y craving. Adicciones, 23 (1), 45-52. http://dx.doi.org/10.20882/adicciones.166
  • Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000). The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: A latent variable analysis. Cognitive psychology, 41(1), 49-100.
  • Mogedas Valladares, A. I., & Alameda Bailén, J. R. (2011). Toma de decisiones en pacientes drogodependientes. http://dx.doi.org/10.20882/adicciones.121
  • Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., ... & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695-699.
  • Ojeda, N., Del, R. P., Ibarretxe-Bilbao, N., Schretlen, D. J., & Pena, J. (2016). Montreal Cognitive Assessment Test: normalization and standardization for Spanish population. Revista de neurologia, 63(11), 488-496.
  • Pace-Schott, E. F., Morgan, P. T., Malison, R. T., Hart, C. L., Edgar, C., Walker, M., & Stickgold, R. (2008). Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. The American journal of drug and alcohol abuse, 34(1), 109-121.
  • Pani, P. P., Trogu, E., Vigna-Taglianti, F., Mathis, F., Diecidue, R., Kirchmayer, U., ... & Saponaro, A. (2014). Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment. Annals of general psychiatry, 13(1), 35.
  • Pani, P. P., Maremmani, A. G. I., Trogu, E., Vigna-Taglianti, F., Mathis, F., Diecidue, R., ... & Camposeragna, A. (2015). Psychopathological symptoms in detoxified and non-detoxified heroindependent patients entering residential treatment. Heroin Addiction and Related Clinical Problems, 17(2-3), 17-24.
  • Pedrero-Pérez, E. J., Puerta-García, C., Segura-López, I., & Martínez-Osorio, S. M. (2004). Evolution of psychopatologic symptoms of drug dependents throughout the treatment. Trastornos Adictivos, 6, 176-191.
  • Piñón-Blanco, A., Gutiérrez-Martínez, O., Vergara Moragues, E., Vázquez-Justo, E., Domínguez, P., ; Guillen-Gestoso, C. Otero-Lamas, F. (2016). Neuropsychological profile of patients with substance-related disorders in semi-residential treatment. Revista Adictologia. Nº3.
  • Reitan, R. M., & Wolfson, D. (1993). The Halstead-Reitan neuropsychological test battery: Theory and clinical applications.
  • Ríos, M., & Muñoz-Céspedes, J. M. (2004). La atención y el control ejecutivo después de un traumatismo craneoencefálico. Madrid: Fundación Mapfre Medicina.
  • Rognoni, T., Casals-Coll, M., Sánchez-Benavides, G., Quintana, M., Manero, R. M., Calvo, L., ... & Peña-Casanova, J. (2013). Spanish normative studies in young adults (NEURONORMA young adults project): Norms for Stroop Color–Word Interference and Tower of London-Drexel University tests. Neurología (English Edition), 28(2), 73-80.
  • Rojo-Mota, G., Pedrero-Pérez, E. J., Ruiz-Sánchez de León, J. M., Llanero-Luque, M., & Puerta-García, C. (2013). Cribado neurocognitivo en adictos a sustancias: la evaluación cognitiva de Montreal. Revista de neurología, 56(3), 129-136.
  • Rolls, E.T. (2004). The functions of the orbitofrontal cortex. Brain and Cognition, 55, 11-29.
  • Ruiz, J.M., Pedrero, E., Llanero, M., Rojo, G., Olivar, A., Bouso, J.C. & Puerta, C. (2009). Perfil neuropsicológico en la adicción a la cocaína: consideraciones sobre el ambiente social próximo de los adictos y el valor predictivo del estado cognitivo en el éxito terapéutico. Adicciones, 21, 119-132.
  • Ruíz Martínez, A. O., Hernández Cera, M. I., Arévalo, M., de Jesús, P. J., Vargas Santillán, M., & Lourdes, D. (2014). Funcionamiento familiar de consumidores de sustancias adictivas con y sin conducta delictiva. Liberabit, 20(1), 109-117.
  • Sohlberg, M. M., & Mateer, C. A. (1989). Introduction to cognitive rehabilitation: Theory and practice. Guilford Press.
  • Schrimsher, G.W. & Parker, J.D. (2008). Changes in cognitive function during substance use disorder treatment. Journal of Psychopathological and Behavioral Assessment, 30, 146-153.
  • Tamayo, F., Casals-Coll, M., Sánchez-Benavides, G., Quintana, M., Manero, R. M., Rognoni, T., ... & Peña-Casanova, J. (2012). Spanish normative studies in a young adult population (NEURONORMA young adults project): Guidelines for the span verbal, span visuo-spatial, Letter-Number Sequencing, Trail Making Test and Symbol Digit Modalities Test. Neurología (English Edition), 27(6), 319-329.
  • Tirapu, J., Landa, N. & Lorea, I. (2004). Cerebro y adicción. Una guía comprensiva. Navarra: Gobierno de Navarra. Departamento de Salud.
  • Vázquez-Justo, E., Piñón-Blanco, A., Vergara-Moragues, E., Guillén-Gestoso, C. y Pérez-García, M. (2014). Cognitive reserve during neuropsychological performance in HIV intravenous drug users. Applied Neuropsychology. Adult, 21, 288-296.
  • Vázquez-Justo, E., Vergara-Moragues, E., Piñón-Blanco, A., Guillén-Gestoso, C. y Pérez-García, M. (2016). Neuropsychological functioning in methadone maintenance patients with HIV. Revista Latinoamericana de Psicología. http://dx.doi.org/10.1016/j.rlp.2015.06.008.
  • Verdejo-García, A., Orozco Giménez, C., Meersmans Sánchez-Jofré, M., Aguilar de Arcos, F. & Pérez García, M. (2004). Impacto de la gravedad del consumo de drogas sobre distintos componentes de la función ejecutiva. Revista de Neurología 38, 1109-1116.
  • Verdejo-García, A., & Bechara, A. (2009). Neuropsicología y drogodependencias: evaluación, impacto clínico y aplicaciones para la rehabilitación. Manual de neuropsicología clínica, 179-208.
  • Verdejo-Garcia, A. (2016). Cognitive training for substance use disorders: Neuroscientific mechanisms. Neuroscience & Biobehavioral Reviews, 68, 270-281.
  • Volkow, N.D., Koob, G.F. & McLellan, A.T. (2016). Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine; 374, 363–371. http://dx.doi.org/10.1056/NEJMra1511480
  • Wechsler D. Escala de inteligencia Wechsler para Adultos III. Madrid: TEA Ediciones. 2001.
  • Woicik, P. A., Moeller, S. J., Alia-Klein, N., Maloney, T., Lukasik, T. M., Yeliosof, O., ... & Goldstein, R. Z. (2009). The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology, 34(5), 1112.
  • Yan W.-S., Li Y.-H., Xiao L., Zhu N., Bechara A. & Sui N. (2014). Working memory and affective decision-making in addiction: A neurocognitive comparison between heroin addicts, pathological gamblers and healthy controls. Drug and Alcohol Dependence, 134 (1) , 194-200. http://dx.doi.org/10.1016/j.drugalcdep.2013.09.027
  • Yücel, M. & Lubman, D. I. (2007). Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug and Alcohol Review, 26, 33-39.
Data source: Dialnet